Drug Shortage Report for DALMACOL
Report ID | 1733 |
Drug Identification Number | 02230769 |
Brand name | DALMACOL |
Common or Proper name | Dalmacol |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | DOXYLAMINE SUCCINATE SODIUM CITRATE HYDROCODONE BITARTRATE ALCOHOL ANHYDROUS ETAFEDRIN HYDROCHLORIDE |
Strength(s) | 1.2MG 40MG .33MG .05ML 3.33MG |
Dosage form(s) | LIQUID |
Route of administration | ORAL |
Packaging size | 500ml & 2L |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2017-03-13 |
Actual start date | 2017-03-13 |
Estimated end date | 2017-05-12 |
Actual end date | 2017-05-09 |
Shortage status | Resolved |
Updated date | 2017-07-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-07-04 | French | Compare |
v6 | 2017-07-04 | English | Compare |
v5 | 2017-03-14 | English | Compare |
v4 | 2017-03-13 | French | Compare |
v3 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 7 of 7